Global Biologics Contract Development & Manufacturing Organization (CDMO) Market—Companies-to-Action

Establishment of Need-based Business Models with Advancements in Manufacturing Techniques is Driving Market Growth

USD 3,000.00

* Required Fields

USD 3,000.00

PAY BY INVOICE

Be the first to review this product

The study on the "Global Biologics Contract Development & Manufacturing Organizations (CDMO) Market: Companies-to-Action" presents an overview of the global biologics development and manufacturing landscape with an emphasis on the seven leading CDMOs in the market. The study highlights the shifting focus and investments of bio-pharma companies toward biologics development and manufacturing, which is attributed to the growing demand for innovative therapies as well as the loss of patent exclusivity of the leading pharma products. The biologics manufacturing industry is presently in a growth stage owing to factors such as complexity of molecules and complex manufacturing processes. This presents an immense potent

Key Issues Addressed

  • What are the current growth opportunities in the bio-CDMO market? What are some of the external factors that affect this market?
  • Which are the key bio-CDMOs that are introducing unique and innovative solutions in the market? How do these solutions transform the market?
  • How will the bio-CDMO market transform the industry paradigms in the next five years?
  • What are the strategic imperatives to be adopted by the bio-CDMOs to bring about this market transformation?
  • What is the growth potential of this rapidly expanding Bio-CDMO market?
  • Which CDMO business model is best suited to meet the growing outsourcing needs of the biopharmaceutical industry?

Table of Contents

Methodology
1. Executive Summary
Key Findings—Analysis of Companies-to-Action
Scope and Segmentation
2. Companies-to-Action Overview
Companies-to-Action Value Creators
Opportunities and Threats
Leading Bio-CDMOs to Watch
3. Companies-to-Action Profiles—Lonza
Business Overview
Company’s Value Propositions
Major Partnerships and Agreements
Revenue and Growth Plans
4. Companies-to-Action Profiles—Boehringer Ingelheim BioXcellence™
Business Overview
Company’s Value Propositions
Major Partnerships and Agreements
Revenue and Growth Plans
5. Companies-to-Action Profiles—Patheon (Acquired by Thermo Fisher Scientific)
Business Overview
Company’s Value Propositions
Major Partnerships and Agreements
Revenue and Growth Plans
6. Companies-to-Watch Profiles—Samsung BioLogics
Business Overview
Company’s Value Propositions
Major Partnerships and Agreements
Revenue and Growth Plans
7. Companies-to-Action Profiles—Catalent
Business Overview
Company’s Value Propositions
Major Partnerships and Agreements
Revenue and Growth Plans
8. Companies-to-Watch Profiles—Wuxi Biologics
Business Overview
Company’s Value Propositions
Major Partnerships and Agreements
Revenue and Growth Plans
9. Companies-to-Action Profiles—AGC Biologics (Previously CMC Biologics)
Business Overview
Company’s Value Propositions
Major Partnerships and Agreements
Revenue and Growth Plans
10. Growth Environment—Business Models and Competitive Playbook
Business Models in Bio-CDMO Market
Company Snapshot—Bio-CDMOs
Competitive Playbook—Market Share Analysis
Case Study—Thermo Fisher: Patheon
Key Mergers, Acquisitions and Partnership Agreements
Key Investments and Facility Expansions
11. Growth Environment and Companies to Action
Transformation in Industry Eco-system
5 Major Growth Opportunities
Strategic Imperatives for Success and Growth
12. The Last Word
Conclusion—Key Takeaways
Legal Disclaimer
13. Appendix
Key Mergers, Acquisitions and Partnership Agreements
Key Investments and Facility Expansions
List of Vendors
List of Exhibits
14. The Frost & Sullivan Story


List of Figures & Charts

1. Total Bio-CDMO Market: Company Snapshot—Bio-CDMOs, Global, 2017
2. Bio-CDMO Market: Key Mergers and Acquisitions, Global, 2016–2017
3. Bio-CDMO Market: Key Mergers and Acquisitions, Global, 2016–2018
4. Bio-CDMO Market: Key Mergers and Acquisitions, Global, 2016
5. Bio-CDMO Market: Facility Expansions and Investments, Global, 2013–2018
6. Bio-CDMO Market: Key Mergers and Acquisitions, Global, 2015–2016
7. Bio-CDMO Market: Key Mergers and Acquisitions, Global, 2014
8. Bio-CDMO Market: Key Mergers and Acquisitions, Global, 2012–2014
9. Bio-CDMO Market: Key Investments and Facility Expansions, Global, 2014–2015


1. Bio-CDMO Market: C2A Value Creators, Global, 2017
2. Bio-CDMO Market: Lonza Revenue Percentage Breakdown by Services Offerings, Global, 2017
3. Bio-CDMO Market: Lonza Overall Sales, Global, 2012–2017
4. Bio-CDMO Market: BI BioXcellence Contract Revenue, Global, 2012–2017
5. Bio-CDMO Market: Patheon Revenue Percentage Breakdown by Services Offerings, Global, 2016
6. Bio-CDMO Market: Patheon Contract Revenue, Global, 2012–2017
7. Bio-CDMO Market: Samsung BioLogics Contract Revenue, Global, 2015–2017
8. Bio-CDMO Market: Catalent Contract Revenue, Global, 2012–2017
9. Bio-CDMO Market: Wuxi Biologics Percentage Breakdown for Services Offerings, Global, 2016
10. Bio-CDMO Market: Business Models, Global, 2017
11. Bio-CDMO Market: Market Share Analysis, Global, 2017
12. Bio-CDMO Market: Major Growth Opportunities, Global, 2017



Keyword1
cmdo
Keyword2

Keyword3
cmdo

Related Research

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.